1. Home
  2. ARQT vs GOGO Comparison

ARQT vs GOGO Comparison

Compare ARQT & GOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • GOGO
  • Stock Information
  • Founded
  • ARQT 2016
  • GOGO 1991
  • Country
  • ARQT United States
  • GOGO United States
  • Employees
  • ARQT N/A
  • GOGO N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • GOGO Telecommunications Equipment
  • Sector
  • ARQT Health Care
  • GOGO Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • GOGO Nasdaq
  • Market Cap
  • ARQT 1.1B
  • GOGO 988.0M
  • IPO Year
  • ARQT 2020
  • GOGO 2013
  • Fundamental
  • Price
  • ARQT $14.99
  • GOGO $7.54
  • Analyst Decision
  • ARQT Strong Buy
  • GOGO Buy
  • Analyst Count
  • ARQT 4
  • GOGO 3
  • Target Price
  • ARQT $15.50
  • GOGO $12.17
  • AVG Volume (30 Days)
  • ARQT 2.2M
  • GOGO 1.3M
  • Earning Date
  • ARQT 11-06-2024
  • GOGO 11-05-2024
  • Dividend Yield
  • ARQT N/A
  • GOGO N/A
  • EPS Growth
  • ARQT N/A
  • GOGO N/A
  • EPS
  • ARQT N/A
  • GOGO 0.43
  • Revenue
  • ARQT $138,708,000.00
  • GOGO $404,720,000.00
  • Revenue This Year
  • ARQT $208.32
  • GOGO $3.79
  • Revenue Next Year
  • ARQT $48.56
  • GOGO $10.69
  • P/E Ratio
  • ARQT N/A
  • GOGO $17.55
  • Revenue Growth
  • ARQT 182.84
  • GOGO N/A
  • 52 Week Low
  • ARQT $2.60
  • GOGO $6.17
  • 52 Week High
  • ARQT $15.77
  • GOGO $11.17
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 67.53
  • GOGO 44.89
  • Support Level
  • ARQT $12.66
  • GOGO $7.63
  • Resistance Level
  • ARQT $15.02
  • GOGO $8.15
  • Average True Range (ATR)
  • ARQT 1.11
  • GOGO 0.36
  • MACD
  • ARQT 0.14
  • GOGO -0.04
  • Stochastic Oscillator
  • ARQT 78.92
  • GOGO 28.24

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Business Aviation. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services. and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.

Share on Social Networks: